financetom
Business
financetom
/
Business
/
Cheesecake Factory has 'Intriguing' Setup Against Consensus in 2026, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cheesecake Factory has 'Intriguing' Setup Against Consensus in 2026, Oppenheimer Says
Apr 21, 2026 8:17 AM

11:13 AM EDT, 04/21/2026 (MT Newswires) -- Cheesecake Factory ( CAKE ) has an "intriguing" setup against consensus in 2026 where same-store sales and EPS forecasts now tilt conservatively, Oppenheimer said Tuesday.

According to the note, the company's core customer remains unaffected amid macro pressures impacting the broader industry. This dynamic, along with Oppenheimer's analysis of consensus, identifies a strong setup against Street's Q1 and Q2 same-store sales forecasts of 0.6% and 0.7%, respectively.

The brokerage believes risk/reward skews favorably against Street's full-year 2026 same-store-sales forecast of 1.1%. Quarterly SSS forecasts possibly discount healthier underlying momentum, new company-specific drivers, and easier comparisons, the brokerage added.

Management's Q1 guidance implied SSS mid-point of 1% and EPS near $1. Meanwhile, Oppenheimer forecasts 1.0% SSS and EPS of $1.01, versus Street consensus of 0.6% and $1, respectively.

The brokerage slightly lifted its 2026 and 2027 EPS estimates to to $4.04 and $4.48 from $4.03 and 4.46, respectively.

The company is scheduled to report Q1 results on April 29.

Oppenheimer maintained an outperform rating on Cheesecake Factory ( CAKE ) and raised the price target to $72 from $68.

Price: 61.90, Change: -0.24, Percent Change: -0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen's results beat estimates on strength in rare disease drugs
Biogen's results beat estimates on strength in rare disease drugs
May 25, 2025
May 1 (Reuters) - Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis medicines. The drugmaker has focused on deals, cost-cutting measures and newer drugs to address investor pressure for growth as demand falls for its once top-selling multiple sclerosis medicines in the face...
Tecsys Acquires Pivotree Assets For $2.7 Million, Establishes India Subsidiary
Tecsys Acquires Pivotree Assets For $2.7 Million, Establishes India Subsidiary
May 25, 2025
08:29 AM EDT, 05/01/2025 (MT Newswires) -- Tecsys ( TCYSF ) on Thursday said it has acquired assets from Pivotree ( PVTRF ) that include select customer contracts and intellectual property for $2.7 million. Tecsys ( TCYSF ) has also established a subsidiary in India. The team there will support warehouse management system (WMS) solutions. It currently delivers services to...
Broadridge Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2025 Outlook Maintained
Broadridge Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2025 Outlook Maintained
May 25, 2025
08:27 AM EDT, 05/01/2025 (MT Newswires) -- Broadridge Financial Solutions ( BR ) reported fiscal Q3 adjusted earnings Thursday of $2.44 per diluted share, up from $2.23 a year earlier. Analysts polled by FactSet expected $2.41. Revenue for the quarter ended March 31 was $1.81 billion, up from $1.73 billion a year earlier. Analysts surveyed by FactSet expected $1.87 billion....
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved